If you have ever marveled at a sunflower's complex beauty, then you've seen one example of the ubiquitous sequence introduced ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Jan. 14, 2025 A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings ...

Dwyer et al. apply multi-contrast post-processing and deep learning to standard MRI scans from a large multiple sclerosis clinical trial to quantify cortical lesions. They show that combining enhanced ...